LDLR and hyperlipoproteinemia type 3: This diminished binding to LDLR places ApoE2 homozygous individuals at a greater risk for type III hyperlipoproteinemia, a genetic disorder characterized by elevated plasma levels of cholesterol and triglycerides (Hatters et al., 2006).